Vir; Dharam

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vir; Dharam.The latest application filed is for "continuous process for the preparation of 2-(1h-imidazol-4-yl) ethanamine and pharmaceutically acceptable salts thereof".

Company Profile

3.11.14

Vir; Dharam - Noida IN
Vir; Dharam - Uttar Pradesh IN
Vir; Dharam - Waukesha WI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Continuous Process For The Preparation Of 2-(1h-imidazol-4-yl) Ethanamine And Pharmaceutically Acceptable Salts Thereof App 20210361785 - Kumar; Sanjeev ; et al.	2021-11-25
Pharmaceutical Composition Comprising Tetrofosmin And Pharmaceutically Acceptable Salts Thereof App 20210145987 - Prasad; Umamaheshwar M. ; et al.	2021-05-20
Continuous process for the preparation of 2-(1H-imidazol-4-yl) ethanamine and pharmaceutically acceptable salts thereof Grant 10,889,549 - Kumar , et al. January 12, 2	2021-01-12
Process for the preparation of tetrofosmin or acid salt thereof Grant 10,836,781 - Prasad , et al. November 17, 2	2020-11-17
Continuous Process For The Preparation Of 2-(1h-imidazol-4-yl) Ethanamine And Pharmaceutically Acceptable Salts Thereof App 20200131137 - Kumar; Sanjeev ; et al.	2020-04-30
An Improved Process For The Preparation Of Tetrofosmin Or Acid Addition Salt Thereof App 20190382423 - PRASAD; Mokkapati Umamaheshwar ; et al.	2019-12-19
Process for the preparation of Lurasidone hydrochloride Grant 10,426,770 - Mishra , et al. October 1, 2	2019-10-01
Process for the preparation of exametazime Grant 10,252,986 - Biswas , et al.	2019-04-09
High-voltage switch for series/parallel applications and tap changer applications Grant 10,176,943 - Golner , et al. J	2019-01-08
Process for the preparation of apixaban and intermediates thereof Grant 9,932,336 - Singh , et al. April 3, 2	2018-04-03
Process For The Preparation Of Apixaban And Intermediates Thereof App 20170313699 - SINGH; Khushwant ; et al.	2017-11-02
An Improved Process For The Preparation Of Lurasidone Hydrochloride App 20170246165 - MISHRA; Vaibhav ; et al.	2017-08-31
Process For The Preparation Of Stable Crystalline Form-i Of Linezolid, Substantially Free Of Residual Solvent App 20170066728 - BISWAS; Sujay ; et al.	2017-03-09
Process For The Preparation Of Exametazime App 20170015620 - BISWAS; Sujay ; et al.	2017-01-19
Process for the preparation of (S)-(+)- or (R)-(-)-10-hydroxy dihydrodibenz[B,F]azepines by enantioselective reduction of 10,11-dihydro-10-OXO-5H-dibenz[B,F]azepines and polymorphs thereof Grant 9,346,760 - Biswas , et al. May 24, 2	2016-05-24
Process for the preparation of azilsartan medoxomil Grant 9,233,955 - Bansal , et al. January 12, 2	2016-01-12
Process for the preparation of aliskiren Grant 9,056,816 - Biswas , et al. June 16, 2	2015-06-16
Process For The Preparation Of Stable Crystalline Form-i Of Linezolid, Substantially Free Of Residual Solvent App 20150025236 - Biswas; Sujay ; et al.	2015-01-22
Process For The Preparation Of Aliskiren App 20140256963 - Biswas; Sujay ; et al.	2014-09-11
Process For The Preparation Of (s)-(+)- Or (r)-(-)-10-hydroxy Dihydrodibenz[b,f]azepines By Enantioselective Reduction Of 10,11-dihydro-10-oxo-5h-dibenz[b,f]azepines And Polymorphs Thereof App 20130345198 - Biswas; Sujay ; et al.	2013-12-26
Process For The Preparation Of Azilsartan Medoxomil App 20130317230 - Bansal; Deepak ; et al.	2013-11-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.